Skip to content
Menu

Fennec Pharmaceuticals Inc. FENC

Full chart Compare
Set alert

Price alert · FENC

All alert types
13.45 USD +0.12 (+0.90%)

Regular-session close

13.45 0.00 0.00%

After hours · Nov 19, 4:01 PM ET

13.20 Day range 13.84
5.65 52-week range 13.85
YTD
+74.68%
1 year
+64.43%

5D +2.85 (+27.19%)

101214ThuFriMonTueWed13.33
Market cap
474.85M
Revenue (ttm)
49.35M
Profit margin
-2.30%
EPS (ttm)
0.03
Shares out
27.43M
P/E ratio
448.33
Forward P/E
16.78
YTD return
+74.68%
1-year return
+64.43%
Volume
460.51K
Avg volume
214.60K
Open
13.40
Previous close
13.33
Day's range
13.20 – 13.84
52-week range
5.65 – 13.85
Beta
0.27
Analysts
Strong Buy
Price target
13.60 (+1.1%)

Key statistics

50-day average
5.08
200-day average
6.71
Enterprise value
156.10M
Price / sales
3.45
Revenue growth
7.00%
Free cash flow
-3.40M
Total cash
40.32M
Total debt
32.10M
Short % of float
11.18%

Fundamental scorecard

12 of 25 checks passed on FENC’s reported financials

ValueGrowthProfitabilityHealthDividend

12of 25 checks passed

  • Value 1 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
FENC Revenue — quarterly 19.61M
FENC Net income — quarterly 4.64M
FENC EPS — quarterly 0.13

Earnings

FENC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.13-0.21-0.08-61.54%
Aug 13, 2024Jun 1, 20240.06-0.20-0.26-433.33%
May 14, 2024Mar 1, 20240.490.41-0.08-16.33%
Mar 21, 2024Dec 1, 20230.02-0.10-0.12-600.00%
Nov 6, 2023Sep 1, 2023-0.11-0.07+0.04+36.36%
Aug 3, 2023Jun 1, 2023-0.18-0.21-0.03-16.67%

Upgrades / downgrades

FENC analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024HC Wainwright & Co.reitBuyBuy
Aug 22, 2024HC Wainwright & Co.mainBuyBuy
Aug 14, 2024Craig-HallummainBuyBuy
May 15, 2024Craig-HallummainBuyBuy
May 15, 2024HC Wainwright & Co.mainBuyBuy
Apr 4, 2024HC Wainwright & Co.mainBuyBuy

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on FENC — it syncs with the Stock Master app.

Insider holders

FENC insider holders
InsiderRelationLatest transactionDateShares held
ANDRADE ROBERT CChief Financial OfficerStock Award(Grant)Dec 1, 2024128,423
HAIGH ADRIAN JChief Operating OfficerConversion of Exercise of derivative securityApr 21, 20240
ISLAM KHALIDDirectorConversion of Exercise of derivative securityNov 15, 2023213,825
RALLIS CHRISTOPHER ANIGERONDirectorConversion of Exercise of derivative securityDec 1, 202452,214
RAYKOV ROSTISLAV CHRISTOVDirectorSaleDec 4, 202466,432

Institution ownership

FENC institution ownership
Holder% heldSharesValueReported
Southpoint Capital Advisors Lp14.84%4,077,21425.32MSep 29, 2024
Sonic Gp LLC 8.76%2,407,35714.95MSep 29, 2024
Solas Capital Management, LLC7.00%1,923,53611.95MSep 29, 2024
DG Capital Management, LLC5.54%1,522,2049.45MSep 29, 2024
Blackrock Inc.4.48%1,229,4777.64MSep 29, 2024
Vanguard Group Inc3.81%1,047,8916.51MSep 29, 2024

Fund ownership

FENC fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund3.19%876,2085.44MSep 29, 2024
iShares Russell 2000 ETF2.04%559,3713.47MOct 30, 2024
Fidelity Small Cap Index Fund0.88%241,0181.50MAug 30, 2024
iShares Russell 2000 Value ETF0.60%165,5101.03MOct 30, 2024
Vanguard Russell 2000 Index Fund0.34%94,580587.34KAug 30, 2024
Schwab Capital Trust-Small Cap Index Fund0.20%55,452344.36KJul 30, 2024